JP2009022763A - Preliminary preparation method of chemical - Google Patents

Preliminary preparation method of chemical Download PDF

Info

Publication number
JP2009022763A
JP2009022763A JP2008204997A JP2008204997A JP2009022763A JP 2009022763 A JP2009022763 A JP 2009022763A JP 2008204997 A JP2008204997 A JP 2008204997A JP 2008204997 A JP2008204997 A JP 2008204997A JP 2009022763 A JP2009022763 A JP 2009022763A
Authority
JP
Japan
Prior art keywords
compartment
infusion
sealed
infusion container
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008204997A
Other languages
Japanese (ja)
Other versions
JP4944850B2 (en
Inventor
Hiroshi Okada
宏 岡田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP2008204997A priority Critical patent/JP4944850B2/en
Publication of JP2009022763A publication Critical patent/JP2009022763A/en
Application granted granted Critical
Publication of JP4944850B2 publication Critical patent/JP4944850B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method of preliminarily combining chemicals desired to be simultaneously dosed with an infusion such as electrolyte solution, amino acid infusion, and glucose. <P>SOLUTION: In an infusion container 16 with a plurality of separate rooms 8, 9 divided by a communicable isolation means 1, the infusion 13 is injected into the separate room 8 and a discharge region 2 is arranged therein, and the separate room 9 is equipped with an injection region 4 but is a vacant room. The chemical desired to be administered simultaneously with the infusion is injected into the vacant room through the injection region to preliminarily prepare the chemical. Accordingly, the chemical is preliminarily dosed in an dispensary room etc. and then delivered to a patient's room or a patient's home and then both chemicals can be mixed while the both rooms are made to communicate with each other by releasing the isolation means at the patient's room or home and administered. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

本発明は、2つ以上の成分を混合して患者に投与するための輸液容器に関する。特に、使用直前に薬液と薬剤とを無菌的に混合して使用することができ、在宅医療患者に適用できる輸液容器に関する。   The present invention relates to an infusion container for mixing and administering two or more components to a patient. In particular, the present invention relates to an infusion container that can be used by aseptically mixing a drug solution and a drug immediately before use and can be applied to a home medical patient.

従来より、還元糖とアミノ酸を含有する輸液、分解し易いアミノ酸、例えばL−トリプトファン、L−システインを含有する輸液には製造時(高圧蒸気滅菌などの熱滅菌時)あるいは保存時の分解・着色を防ぐために、1)輸液のpHを3.0〜6.0の範囲に調整し、かつ安定剤として亜硫酸塩を添加することにより、一剤化しているもの、2)剥離可能な隔壁を有する二室容器としているもの(特開昭63−19149号公報)、またpHや安定剤の亜硫酸塩に影響を受け易い薬剤、例えばビタミン類や抗生物質等を輸液に添加する場合は、3)薬剤とキット化しているもの(特開平10−24088号公報)、4)使用直前に混合するためにプレフィルドシリンジとしているもの(特開平7−51369号公報)などが提案されている。   Conventionally, infusions containing reducing sugars and amino acids, and infusions containing easily degradable amino acids such as L-tryptophan and L-cysteine are decomposed and colored at the time of manufacture (at the time of heat sterilization such as high-pressure steam sterilization) or during storage. In order to prevent this, 1) the pH of the infusion solution is adjusted to the range of 3.0 to 6.0 and sulfite is added as a stabilizer, and 2) it has a peelable partition wall. What is used as a two-chamber container (Japanese Patent Laid-Open No. 63-19149), or drugs that are easily affected by pH or stabilizer sulfites, such as vitamins and antibiotics, 3) And a kit (Japanese Patent Laid-Open No. 10-24088) and 4) a prefilled syringe for mixing immediately before use (Japanese Patent Laid-Open No. 7-51369) have been proposed.

しかし、従来の容器は薬剤添加の簡便性や在宅医療などへの適用には改良の余地がある。
そこで本発明の課題は、薬液に他の薬剤を添加する場合、例えば電解質輸液、アミノ酸輸液、高カロリー輸液及び経腸栄養剤にビタミン類や抗生物質等を添加して在宅医療等に用いる場合、添加した薬剤が分解することなく安全に、しかも簡便に調製できる輸液容器を提供することにある。
However, the conventional container has room for improvement in application to the convenience of drug addition and home medical care.
Therefore, the problem of the present invention is that when adding other drugs to the drug solution, for example, when adding vitamins, antibiotics, etc. to electrolyte solution, amino acid solution, high calorie solution and enteral nutrition, etc. An object of the present invention is to provide an infusion container that can be prepared safely and conveniently without decomposition of the added drug.

すなわち、本発明は、これらの既存の形態の容器に空室を設け、以下の輸液容器を提供することにより上記課題が解決されたものである。
1)熱可塑性樹脂製フィルムからなる袋体に連通可能な隔離手段により液密に区切られた複数の分室と、前記複数の分室の一つに排出部位、他の分室の一つに注入部位が形成された輸液容器において、前記排出部位を有する分室には薬液又は固形剤が収容され、注入部位を有する分室は空室であることを特徴とする輸液容器である。
2)熱可塑性樹脂製フィルムからなる袋体に連通可能な隔離手段により液密に区切られた二つの分室のうちの第1分室に排出部位、第2分室に注入部位が形成された輸液容器において、前記第1分室に薬液が収容され、第2分室は空室であり、かつ隔離手段は前記分室のいずれか一方を外面より押圧して生じる内圧によって解除されることを特徴とする輸液容器である。
3)熱可塑性樹脂製フィルムからなる袋体に連通可能な隔離手段により液密に区切られた三つの分室の第1分室に排出部位、第2分室に固着端部及び第3分室に注入部位が形成された輸液容器において、前記第1分室及び第2分室には薬液又は固形剤が収容され、第3分室は空室であり、かつ隔離手段は前記分室のいずれかを外面より押圧して生じる内圧によって解除されることを特徴とする輸液容器。
4)前記隔離手段が、熱可塑性樹脂製フィルムからなる袋体の内壁同士を加熱、押圧して形成された熱シールであることを特徴とする輸液容器である。
5)前記分室にはpHが3.0〜6.0に維持され、安定剤として亜硫酸塩を含有する輸液が収容されていることを特徴とする輸液容器である。
That is, the present invention solves the above-mentioned problems by providing empty containers in these existing containers and providing the following infusion containers.
1) A plurality of compartments separated in a liquid-tight manner by isolation means that can communicate with a bag made of a thermoplastic resin film, a discharge part in one of the plurality of compartments, and an injection part in one of the other compartments In the infusion container thus formed, a chemical solution or a solid agent is accommodated in the compartment having the discharge part, and the compartment having the injection part is an empty container.
2) In an infusion container in which a discharge part is formed in a first compartment and an injection part is formed in a second compartment of two compartments separated liquid-tightly by a separating means that can communicate with a bag made of a thermoplastic resin film. The infusion container is characterized in that a chemical solution is stored in the first compartment, the second compartment is an empty chamber, and the separating means is released by an internal pressure generated by pressing one of the compartments from the outer surface. is there.
3) A discharge part is provided in the first compartment of the three compartments separated in a liquid-tight manner by a separating means that can communicate with a bag made of a thermoplastic resin film, a fixed end part in the second compartment, and an injection part in the third compartment. In the formed infusion container, the first compartment and the second compartment contain a chemical solution or solid agent, the third compartment is an empty room, and the separating means is generated by pressing one of the compartments from the outer surface. An infusion container which is released by internal pressure.
4) The infusion container characterized in that the isolation means is a heat seal formed by heating and pressing inner walls of a bag made of a thermoplastic resin film.
5) The infusion container is characterized in that the compartment is maintained at a pH of 3.0 to 6.0 and contains an infusion containing sulfite as a stabilizer.

前記隔離手段1は熱シールが施されている。熱シール強度の調整は、特に限定しないが、シール温度、シール時間及びシール圧力の変化によって、また熱シール部分の幅や深さなどにより調整することができる。更に、隔離手段は特に限定する必要はなく、熱可塑性樹脂製フィルムからなる袋体の内壁同士を加熱、押圧して形成された熱シールや、袋体の外面から挟むシールバー、隔離部に形成されるクリックチップなどが挙げられる。   The isolation means 1 is heat sealed. Adjustment of the heat seal strength is not particularly limited, but can be adjusted by changes in the seal temperature, seal time, and seal pressure, and by the width and depth of the heat seal portion. Further, the isolation means is not particularly limited, and is formed on a heat seal formed by heating and pressing inner walls of a bag made of a thermoplastic resin film, a seal bar sandwiched from the outer surface of the bag, or an isolation part. Click chip to be used.

また、輸液容器における隔離手段1の熱シールの形成方法としては、特に限定されず、通常使用されている熱シールバー等を用いて行うことができる。また、オートクレーブ滅菌等の熱滅菌時に隔離手段1の部位を外側から狭持体で保持したまま高圧蒸気滅菌し、その際に生じる樹脂のブロッキングによってシールする方法を用いても良い。   Moreover, it does not specifically limit as a formation method of the heat seal of the isolation means 1 in an infusion container, It can carry out using the heat seal bar etc. which are used normally. Alternatively, a method may be used in which autoclave sterilization or the like is performed by high-pressure steam sterilization while the part of the isolation means 1 is held by a holding body from the outside and sealed by resin blocking that occurs at that time.

本発明において隔離手段の強度の実測値は、通常の人が平面上にのせて上から手の平で押圧して解除できる範囲であれば特に限定されない。例を挙げると、隔離手段を10〜90g/cm2、好ましくは20〜60g/cm2の内圧を加えることにより解除されるよう設定する。 In the present invention, the actually measured value of the strength of the separating means is not particularly limited as long as it is within a range that a normal person can put on a flat surface and press and release with a palm from above. By way of example, 10~90g / cm 2 the isolation means, preferably configured to be released by adding an internal pressure of 20 to 60 g / cm 2.

また、分室の数は二室に限らず、三室又はそれ以上の分室が形成されていてもよい。そして、複数の分室の一つに排出部位、他の分室の一つに注入部位が設けられる。特に、注入部位側の分室を空室とするのが好ましい。   Further, the number of compartments is not limited to two, and three or more compartments may be formed. A discharge site is provided in one of the plurality of compartments, and an injection site is provided in one of the other compartments. In particular, it is preferable to make the compartment on the injection site side empty.

更に、三室又はそれ以上の分室が形成されている場合、それぞれの分室を開通させるための隔離手段の強度を変化させることもできる。   Further, when three or more compartments are formed, the strength of the separating means for opening each compartment can be changed.

また、一端には排出部位として固着シール部6に挟まれるようにして排出管2が設けられ、他端には注入部位として固着シール部7に挟まれるようにして排出管2より細径の注入管4が設けられ、各々栓体3、栓体5によって封止されている。また、必要により吊り下げるための穴10が設けられる。   Further, the discharge pipe 2 is provided at one end so as to be sandwiched between the fixed seal portion 6 as a discharge portion, and the other end is injected with a smaller diameter than the discharge pipe 2 so as to be sandwiched between the fixed seal portion 7 as an injection portion. A tube 4 is provided and sealed with a plug 3 and a plug 5 respectively. Moreover, the hole 10 for hanging is provided if necessary.

本発明の輸液容器に用いられる熱可塑性樹脂製フィルムは、直鎖状低密度ポリエチレンからなり、チューブ状樹脂のシートはインフレーション成形により形成されたものであるが、インフレーション成形物である必要はなく、押し出し成形物、真空成形物、射出成形物、ブロー成形物等でも良い。   The thermoplastic resin film used in the infusion container of the present invention is made of linear low-density polyethylene, and the tubular resin sheet is formed by inflation molding, but it is not necessary to be an inflation molded product, Extruded molded products, vacuum molded products, injection molded products, blow molded products and the like may be used.

本発明における熱可塑性樹脂としては、特に限定する必要はなく、ポリエチレン、ポリプロピレン、ポリ塩化ビニル、エチレン−酢酸ビニル共重合体、ポリアミド、ポリビニリデンクロライド、ポリビニルフルオライド、ポリトリフルオルクロルエチレン、ポリエチレンテレフタレート、ポリエステル、ポリオレフィン系樹脂およびこれらの混合物や積層体が挙げられる。本発明の輸液容器は衛生面、安全面を考慮して製造後、高圧蒸気滅菌等の熱滅菌や、高周波滅菌などの滅菌処理をすることが好ましく、それらに耐えられる材質が良い。   The thermoplastic resin in the present invention is not particularly limited, and polyethylene, polypropylene, polyvinyl chloride, ethylene-vinyl acetate copolymer, polyamide, polyvinylidene chloride, polyvinyl fluoride, polytrifluorochloroethylene, polyethylene terephthalate. , Polyester, polyolefin resin, and mixtures and laminates thereof. The infusion container of the present invention is preferably subjected to heat sterilization such as high-pressure steam sterilization or high-frequency sterilization after manufacturing in consideration of hygiene and safety, and a material that can withstand these is preferable.

本発明の輸液容器の空室には、予め、医師又は看護婦が輸液と同時に投与したい薬剤を入れておくことができる。これにより、1)添加したい薬剤入りのダブルバックを簡単に調製できる(薬剤ごとに組み合わせたダブルバッグを購入しないで病院で多種類の薬剤との組み合わせが可能である。2)バッグに入っている薬液に薬剤を添加すると安定性に問題が生じる時、予めナースセンターで調製し、使用直前に混合することができる。3)病室では隔離手段を解除することより簡単に混合でき、医療現場の合理化に役立つ。4)在宅医療にも有用である。   A medicine which a doctor or a nurse wants to administer at the same time as the infusion can be put in the empty room of the infusion container of the present invention in advance. As a result, 1) a double bag containing the medicine to be added can be easily prepared (a combination with various kinds of drugs is possible in a hospital without purchasing a double bag for each medicine. 2) It is contained in a bag. When there is a problem in stability when a drug is added to the drug solution, it can be prepared in advance at a nurse center and mixed immediately before use. 3) In a hospital room, mixing can be done more easily by releasing the isolation means, which helps streamline the medical field. 4) It is also useful for home medical care.

従って、本発明の輸液容器を用いることにより、電解質輸液、アミノ酸輸液、高カロリー輸液及び経腸栄養剤などの薬液に他の薬剤を混合して在宅医療に適用する場合でも、簡便な操作で混合でき、薬剤が分解することなく安全に投与することができる。   Therefore, by using the infusion container of the present invention, even when other drugs are mixed with medicinal solutions such as electrolyte infusion, amino acid infusion, high calorie infusion and enteral nutrition, they are mixed by a simple operation. And can be safely administered without degradation of the drug.

本発明の輸液容器は、電解質輸液、アミノ酸輸液、高カロリー輸液及び経腸栄養剤等の薬液にビタミン類や抗生物質などの薬剤を用時混合して使用することができるので、在宅医療患者に適用するまで薬剤の分解する虞がない。   The infusion container of the present invention can be used by mixing medicines such as vitamins and antibiotics with electrolytes, amino acid infusions, high-calorie infusions, enteral nutrients, etc. There is no risk of chemical degradation until application.

本発明の輸液容器について、以下の図面を参照しながら詳述するが、何らこれらに限定されるものではない。
図1は本発明の輸液容器の第一実施例の正面図である。輸液容器の端部6、7は、完全に固着シールされ、袋体のシート内壁同士の熱シールにより形成された可能な隔離手段1により、第1分室8、第2分室9が形成され、第1分室8には排出管2が設けられ、第2分室9には注入管4が設けられている。分室8には薬液が無菌状態で封入され、分室9は空室となっている。
The infusion container of the present invention will be described in detail with reference to the following drawings, but is not limited thereto.
FIG. 1 is a front view of a first embodiment of the infusion container of the present invention. The end portions 6 and 7 of the infusion container are completely fixed and sealed, and the first compartment 8 and the second compartment 9 are formed by the possible isolation means 1 formed by heat sealing between the inner sheet walls of the bag. The first branch chamber 8 is provided with a discharge pipe 2, and the second branch chamber 9 is provided with an injection pipe 4. A chemical solution is sealed in the compartment 8 in a sterile state, and the compartment 9 is an empty room.

図2は本発明の輸液容器の第二実施例の正面図である。輸液容器の端部6、7は、完全に固着シールされ、袋体のシート内壁同士の熱シールにより形成された可能な隔離手段1により、第1分室8、第2分室9及び第3分室11が形成され、第1分室8には排出管2が設けられ、第3分室11には注入管4が設けられ、第2分室9の側部には薬剤充填後、固着端部が形成される。分室8、9には薬液が無菌状態で封入され、分室11は空室となっている。   FIG. 2 is a front view of a second embodiment of the infusion container of the present invention. The end portions 6 and 7 of the infusion container are completely fixed and sealed, and the first compartment 8, the second compartment 9, and the third compartment 11 are formed by possible isolation means 1 formed by heat sealing between the inner sheet walls of the bag. The discharge chamber 2 is provided in the first compartment 8, the injection tube 4 is provided in the third compartment 11, and the fixed end portion is formed on the side of the second compartment 9 after filling the medicine. . The compartments 8 and 9 are filled with a chemical solution in a sterile state, and the compartment 11 is an empty room.

図3は本発明の輸液容器の第三実施例の正面図である。輸液容器の端部6、7は、完全に固着シールされ、袋体のシート内壁同士の熱シールにより形成された可能な隔離手段1により、第1分室8、第2分室9及び第3分室11が形成され、第1分室8には排出管2が設けられ、第3分室11には注入管4が設けられ、第2分室9の側部には薬剤充填後、固着端部が形成される。分室8には薬液が、分室9には粉末剤が無菌状態で封入され、分室11は空室となっている。   FIG. 3 is a front view of a third embodiment of the infusion container of the present invention. The end portions 6 and 7 of the infusion container are completely fixed and sealed, and the first compartment 8, the second compartment 9, and the third compartment 11 are formed by possible isolation means 1 formed by heat sealing between the inner sheet walls of the bag. The discharge chamber 2 is provided in the first compartment 8, the injection tube 4 is provided in the third compartment 11, and the fixed end portion is formed on the side of the second compartment 9 after filling the medicine. . The compartment 8 is filled with a chemical solution, the compartment 9 is filled with a powder in an aseptic manner, and the compartment 11 is empty.

図4は本発明の輸液容器の第四実施例の正面図である。輸液容器の端部6、7は、完全に固着シールされた袋体から構成されている。さらに前記袋体の適当な位置でシールバー12により袋体の両側から挟んで閉鎖され、第1分室8、第2分室9が形成され、第1分室8には排出管2が設けられ、第2分室9には注入管4が設けられている。分室8には薬液が無菌状態で封入され、分室9は空室となっている。   FIG. 4 is a front view of a fourth embodiment of the infusion container of the present invention. The end portions 6 and 7 of the infusion container are formed of a bag body that is completely fixed and sealed. Further, the bag body is closed at an appropriate position by the seal bar 12 from both sides of the bag body to form a first compartment 8 and a second compartment 9, and the first compartment 8 is provided with a discharge pipe 2. An injection tube 4 is provided in the half chamber 9. A chemical solution is sealed in the compartment 8 in a sterile state, and the compartment 9 is an empty room.

図5は本発明の輸液容器の第五実施例の正面図である。輸液容器の端部6、7は、完全に固着シールされた袋体から構成されている。さらに前記袋体の適当な位置でクリックチップが内壁に挟まれるように液密に取り付けられ、第1分室8、第2分室9が形成され、第1分室8には排出管2が設けられ、第2分室9には注入管4が設けられている。分室8には薬液が無菌状態で封入され、分室9は空室となっている。   FIG. 5 is a front view of a fifth embodiment of the infusion container of the present invention. The end portions 6 and 7 of the infusion container are formed of a bag body that is completely fixed and sealed. Further, the click chip is attached in a liquid-tight manner so that the click tip is sandwiched between the inner walls at an appropriate position of the bag body, the first compartment 8 and the second compartment 9 are formed, and the discharge pipe 2 is provided in the first compartment 8; An injection tube 4 is provided in the second compartment 9. A chemical solution is sealed in the compartment 8 in a sterile state, and the compartment 9 is an empty room.

次に、本発明の輸液容器の使用方法について説明する。
使用方法1として隔離手段に熱シールが施されている二室容器の場合、栓体5より注射器等を用いて第2分室9に必要に応じてビタミン剤や抗生物質等の薬剤を無菌的に注入する。ついで、使用直前に分室のいずれか一つ、好ましくは排出部位から近いほうの分室の外面を手で押圧することにより生じる分室内の内圧によって隔離手段1の熱シールを剥離させ、第1分室8内の薬液と第2分室9内の薬剤とを混合する。その後、栓体3より瓶針等を差し込み混合液を排出させる。
Next, the usage method of the infusion container of this invention is demonstrated.
In the case of a two-chamber container in which the isolating means is heat-sealed as the method of use 1, aseptic medicines such as vitamins and antibiotics are aseptically applied to the second compartment 9 from the stopper 5 using a syringe or the like. inject. Then, immediately before use, the heat seal of the separating means 1 is peeled off by the internal pressure generated by manually pressing one of the compartments, preferably the outer surface of the compartment closer to the discharge site, and the first compartment 8 The chemical solution in the inside and the medicine in the second compartment 9 are mixed. Thereafter, a bottle needle or the like is inserted from the plug 3 to discharge the mixed solution.

使用方法2として隔離手段に熱シールが施されている三室容器の場合、栓体5より注射器等を用いて第3分室11に必要に応じてビタミン剤や抗生物質等の薬剤を無菌的に注入する。ついで、使用直前に分室のいずれかを、好ましくは排出部位から近いほうの分室の外面を手で押圧することにより、それにより生じる分室内の内圧によって隔離手段1の熱シールを同時もしくは連鎖的に剥離させ、第1分室8、第2分室9内の薬液及び第3分室11内の薬剤とを混合する。その後、栓体3より瓶針等を差し込み混合液を排出させる。   In the case of a three-chamber container in which the isolation means is heat-sealed as method of use 2, a medicine such as a vitamin or antibiotic is aseptically injected into the third compartment 11 from the stopper 5 using a syringe or the like as required. To do. Subsequently, by pressing one of the compartments immediately before use, preferably the outer surface of the compartment closer to the discharge site, by hand, the heat seal of the separating means 1 is simultaneously or chained by the internal pressure generated by the compartment. The chemical solution in the first compartment 8 and the second compartment 9 and the medicine in the third compartment 11 are mixed. Thereafter, a bottle needle or the like is inserted from the plug 3 to discharge the mixed solution.

使用方法3として隔離手段にシールバー方式が用いられている場合、栓体5より注射器等を用いて第2分室9に必要に応じてビタミン剤や抗生物質等の薬剤を無菌的に注入する。ついで、使用直前にシールバー12を解除することにより第1分室8と第2分室9を連通させ、混合する。その後、栓体3より瓶針等を差し込み混合液を排出させる。   When the seal bar method is used as the isolating means as the usage method 3, a medicine such as a vitamin or antibiotic is aseptically injected into the second compartment 9 from the stopper 5 using a syringe or the like as necessary. Next, the first compartment 8 and the second compartment 9 are brought into communication by releasing the seal bar 12 immediately before use and mixing. Thereafter, a bottle needle or the like is inserted from the plug 3 to discharge the mixed solution.

使用方法4として隔離手段にクリックチップが用いられている場合、栓体5より注射器等を用いて第2分室9に必要に応じてビタミン剤や抗生物質等の薬剤を無菌的に注入する。ついで、クリックチップの閉止端の先端を折り取ることにより、開放型とし、第1分室8と第2分室9を連通させ、混合する。その後、栓体3より瓶針等を差し込み混合液を排出させる。   When a click chip is used as the isolating means as the usage method 4, a medicine such as a vitamin or antibiotic is aseptically injected into the second compartment 9 from the stopper 5 using a syringe or the like as necessary. Next, the tip end of the closed end of the click tip is broken to form an open type, and the first compartment 8 and the second compartment 9 are communicated and mixed. Thereafter, a bottle needle or the like is inserted from the plug 3 to discharge the mixed solution.

なお、特に上述した使用方法に限定されず、瓶針等は隔離手段を解除する前に、予め栓体3に刺し込んでおいても良い。また、吊り下げるための穴10を介して吊り下げることにより効率よく投与が可能となる。   In addition, it is not limited to the usage method in particular mentioned above, A bottle needle etc. may be previously stabbed in the stopper 3 before releasing the isolation | separation means. Moreover, administration can be efficiently performed by hanging through the hole 10 for hanging.

分室8又は9に収容する薬液としては、特に限定しないが、重炭酸塩、グルコース、アミノ酸、ペプチド、脂肪、有機酸等を配合した輸液又はそれらの粉末剤が挙げられる。また通常、注入部位側の分室が空室とされ、必要に応じてビタミン類、抗生物質等の薬剤が注入される。   Although it does not specifically limit as a chemical | medical solution accommodated in the compartment 8 or 9, The infusion liquid which mix | blended bicarbonate, glucose, an amino acid, a peptide, a fat, an organic acid, etc., or those powder agents are mentioned. Usually, the compartment on the injection site side is vacant, and drugs such as vitamins and antibiotics are injected as needed.

本発明の輸液容器は、以下の方法により製造される。なお、これらの製造方法に限定する必要はない。 The infusion container of the present invention is manufactured by the following method. In addition, it is not necessary to limit to these manufacturing methods.

本発明の輸液容器は、インフレーション成形して作製したチューブ状のシートを所定の大きさに裁断し、その両端部に熱溶着により完全な固着シール部の形成と同時に排出管、注入管が設けられる。その容器の所定位置には袋体の外側から連通可能な隔離手段1が形成される。そして、隔離手段により容器に複数の分室が形成される。   In the infusion container of the present invention, a tube-shaped sheet produced by inflation molding is cut into a predetermined size, and a discharge tube and an injection tube are provided at the same time as forming a completely fixed seal portion by thermal welding at both ends thereof. . Isolation means 1 that can communicate from the outside of the bag body is formed at a predetermined position of the container. A plurality of compartments are formed in the container by the isolating means.

第一実施例は、上記のようにして作製した容器の第1分室8には排出管2よりアミノ酸輸液が充填され、排出管2が栓体3で封止される。第2分室9は空室とし、注入部位4を栓体5で封止される。日本薬局方の蒸気滅菌の基準に基づいて、オートクレーブ滅菌処理が105〜130℃の範囲で行われた。   In the first embodiment, the first compartment 8 of the container produced as described above is filled with the amino acid infusion solution through the discharge pipe 2, and the discharge pipe 2 is sealed with the stopper 3. The second compartment 9 is an empty chamber, and the injection site 4 is sealed with a plug 5. Based on the standard of steam sterilization of the Japanese Pharmacopoeia, the autoclave sterilization process was performed in the range of 105-130 degreeC.

第二実施例は、上記のようにして作製した容器の第1分室8には排出管2より糖質輸液が充填され、排出管2が栓体3で封止される。次に第2分室9の側部には薬剤充填用の開口部が形成され、かかる開口部からアミノ酸輸液が充填された後、開口部が熱溶着シール密封され、固着端部17が形成される。第3分室11は空室とし、注入管4を栓体5で封止される。日本薬局方の蒸気滅菌の基準に基づいて、オートクレーブ滅菌処理が105〜130℃の範囲で行われた。   In the second embodiment, the first compartment 8 of the container produced as described above is filled with a saccharide infusion solution through the discharge pipe 2, and the discharge pipe 2 is sealed with a plug 3. Next, an opening for filling the medicine is formed in the side portion of the second compartment 9, and after filling the amino acid infusion solution from the opening, the opening is sealed with a heat-sealing seal to form a fixed end portion 17. . The third compartment 11 is an empty room, and the injection tube 4 is sealed with a plug 5. Based on the standard of steam sterilization of the Japanese Pharmacopoeia, the autoclave sterilization process was performed in the range of 105-130 degreeC.

第三実施例は、上記のようにして作製した容器の第1分室8には排出管2より糖質輸液が充填され、排出管2は栓体3で封止される。第3分室11は空室とされ、注入管4は栓体5で封止される。次に日本薬局方の蒸気滅菌の基準に基づいて、オートクレーブ滅菌処理が105〜130℃の範囲で行われた。次に第2分室9の側部には薬剤充填用の開口部が形成され、かかる開口部から炭酸水素ナトリウムが充填された後、開口部が熱溶着シール密封され、固着端部17が形成される。そして、第2分室が電子線照射滅菌される。   In the third embodiment, the first compartment 8 of the container produced as described above is filled with a saccharide infusion solution through the discharge pipe 2, and the discharge pipe 2 is sealed with a plug 3. The third compartment 11 is an empty chamber, and the injection tube 4 is sealed with a plug 5. Next, based on the steam sterilization standard of the Japanese Pharmacopoeia, the autoclave sterilization process was performed in the range of 105-130 degreeC. Next, an opening for filling the medicine is formed on the side of the second compartment 9, and after filling with sodium hydrogen carbonate from the opening, the opening is sealed with a heat-sealing seal, and a fixed end 17 is formed. The Then, the second compartment is sterilized by electron beam irradiation.

第四実施例は、上記のようにして作製した容器の所定胴部にシールバーを用いた隔離手段により、分室を形成した後、排出管2よりアミノ酸輸液を第1分室8に充填し、排出管2が栓体3で封止される。第2分室9は空室とし、注入管が栓体5で封止される。日本薬局方の蒸気滅菌の基準に基づいて、オートクレーブ滅菌処理が105〜130℃の範囲で行われた。   In the fourth embodiment, after a compartment is formed by a separating means using a seal bar in a predetermined body portion of the container produced as described above, the amino acid infusion solution is filled into the first compartment 8 from the discharge pipe 2 and discharged. The tube 2 is sealed with a plug 3. The second compartment 9 is an empty chamber, and the injection tube is sealed with a stopper 5. Based on the standard of steam sterilization of the Japanese Pharmacopoeia, the autoclave sterilization process was performed in the range of 105-130 degreeC.

第五実施例は、上記のようにして作製した容器の所定胴部にクリックチップを用いた隔離手段により、分室を形成した後、排出管2よりアミノ酸輸液を第1分室8に充填し、排出管2が栓体3で封止される。第2分室9は空室とし、注入管が栓体5で封止される。日本薬局方の蒸気滅菌の基準に基づいて、オートクレーブ滅菌処理が105〜130℃の範囲で行われた。   In the fifth embodiment, after a compartment is formed in the predetermined body of the container produced as described above by means of separation using a click chip, the amino acid infusion solution is filled into the first compartment 8 from the discharge pipe 2 and discharged. The tube 2 is sealed with a plug 3. The second compartment 9 is an empty chamber, and the injection tube is sealed with a stopper 5. Based on the standard of steam sterilization of the Japanese Pharmacopoeia, the autoclave sterilization process was performed in the range of 105-130 degreeC.

本発明の輸液容器の第一実施例の正面図である。It is a front view of the 1st Example of the infusion container of this invention. 本発明の輸液容器の第二実施例の正面図である。It is a front view of the second embodiment of the infusion container of the present invention. 本発明の輸液容器の第三実施例の正面図である。It is a front view of the third embodiment of the infusion container of the present invention. 本発明の輸液容器の第四実施例の正面図である。It is a front view of 4th Example of the infusion container of this invention. 本発明の輸液容器の第五実施例の正面図である。It is a front view of 5th Example of the infusion container of this invention.

符号の説明Explanation of symbols

1:隔離手段
2:排出部位
3、5:栓体
4:注入部位
6、7:固着シール部
8:第一分室
9:第二分室
10:吊り下げるための穴
11:第三分室
12:シールバー
13、14:薬液
15:固形剤
16:輸液容器
17:固着端部
18:クリックチップ
1: Separation means 2: Ejection site 3, 5: Plug body 4: Injection site 6, 7: Fixed seal 8: First compartment 9: Second compartment 10: Hole for hanging 11: Third compartment 12: Seal Bars 13 and 14: Chemical solution 15: Solid agent 16: Infusion container 17: Fixed end 18: Click tip

Claims (5)

熱可塑性樹脂製フィルムからなる袋体に連通可能な隔離手段により液密に区切られた複数の分室と、前記複数の分室の一つに排出部位、他の分室の一つに栓体で封止されている注入部位が形成された輸液容器であって、前記排出部位を有する分室には薬液又は固形剤が収容され、栓体で封止されている注入部位を有する分室は注入用空室であることを特徴とする輸液容器において、輸液と同時に投与したい薬剤を該空室に入れておくことを特徴とする薬剤の予備調製方法。   A plurality of compartments separated in a liquid-tight manner by isolation means capable of communicating with a bag body made of a thermoplastic resin film, one of the plurality of compartments is sealed with a discharge portion, and one of the other compartments is sealed with a stopper. An infusion container in which an injection site is formed, wherein the chamber having the discharge site contains a chemical or solid agent, and the chamber having the injection site sealed with a stopper is an injection chamber. A pre-preparation method for a drug, characterized in that, in an infusion container, the drug to be administered simultaneously with the infusion is placed in the empty chamber. 熱可塑性樹脂製フィルムからなる袋体に連通可能な隔離手段により液密に区切られた二つの分室の第1分室に排出部位、第2分室に栓体で封止されている注入部位が形成された輸液容器であって、前記第1分室に薬液が収容され、第2分室は注入用空室であり、かつ隔離手段は前記分室のいずれか一方を外面より押圧して生じる内圧によって解除されることを特徴とする輸液容器において、輸液と同時に投与したい薬剤を該空室に入れておくことを特徴とする薬剤の予備調製方法。   A discharge part is formed in the first compartment of the two compartments separated liquid-tightly by a separating means that can communicate with the bag made of a thermoplastic resin film, and an injection part sealed with a stopper is formed in the second compartment. The infusion container, wherein the first compartment is filled with the chemical solution, the second compartment is an injection chamber, and the separating means is released by an internal pressure generated by pressing one of the compartments from the outer surface. In the infusion container characterized by the above, a medicine pre-preparation method characterized in that a medicine to be administered simultaneously with the infusion is placed in the empty chamber. 熱可塑性樹脂製フィルムからなる袋体に連通可能な隔離手段により液密に区切られた三つの分室の第1分室に排出部位、第2分室に固着端部及び第3分室に栓体で封止されている注入部位が形成された輸液容器であって、前記第1分室及び第2分室には薬液又は固形剤が収容され、第3分室は注入用空室であり、かつ隔離手段は前記分室のいずれかを外面より押圧して生じる内圧によって解除されることを特徴とする輸液容器において、輸液と同時に投与したい薬剤を該空室に入れておくことを特徴とする薬剤の予備調製方法。   Sealed with a discharge part in the first compartment of the three compartments separated liquid-tightly by a separating means that can communicate with the bag made of a thermoplastic resin film, a fixed end in the second compartment, and a plug in the third compartment An infusion container in which an injection site is formed, wherein the first compartment and the second compartment contain a chemical solution or a solid agent, the third compartment is an injection vacancy, and the isolation means is the compartment A method for pre-preparing a drug, wherein a drug to be administered simultaneously with the infusion is placed in the empty chamber in an infusion container characterized in that the drug is released by an internal pressure generated by pressing any of the above from the outer surface. 前記隔離手段が、熱可塑性樹脂製フィルムからなる袋体の内壁同士を加熱、押圧して形成された熱シールであることを特徴とする請求項1〜3のいずれかに記載の薬剤の予備調製方法。   The said isolation | separation means is the heat seal formed by heating and pressing the inner walls of the bag which consists of a film made from a thermoplastic resin, The preliminary preparation of the chemical | medical agent in any one of Claims 1-3 characterized by the above-mentioned. Method. 排出部位を有する前記分室にはpHが3.0〜6.0に維持され、安定剤として亜硫酸塩を含有する輸液が収容されていることを特徴とする請求項1〜4のいずれかに記載の薬剤の予備調整方法。   The said compartment which has a discharge | emission part is maintained at pH 3.0-6.0, and the infusion solution which contains a sulfite as a stabilizer is accommodated in any one of Claims 1-4 characterized by the above-mentioned. Drug preconditioning method.
JP2008204997A 2008-08-08 2008-08-08 Drug pre-preparation method Expired - Fee Related JP4944850B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008204997A JP4944850B2 (en) 2008-08-08 2008-08-08 Drug pre-preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008204997A JP4944850B2 (en) 2008-08-08 2008-08-08 Drug pre-preparation method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP10122190A Division JPH11313871A (en) 1998-05-01 1998-05-01 Infusion vessel

Publications (2)

Publication Number Publication Date
JP2009022763A true JP2009022763A (en) 2009-02-05
JP4944850B2 JP4944850B2 (en) 2012-06-06

Family

ID=40395128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008204997A Expired - Fee Related JP4944850B2 (en) 2008-08-08 2008-08-08 Drug pre-preparation method

Country Status (1)

Country Link
JP (1) JP4944850B2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6319149A (en) * 1986-07-10 1988-01-26 株式会社新素材総合研究所 Medical container and its production
JPH0399667A (en) * 1989-09-14 1991-04-24 Terumo Corp Container for medical care
JPH0614975A (en) * 1992-05-03 1994-01-25 Otsuka Pharmaceut Factory Inc Double-chamber container
JPH07178151A (en) * 1993-10-13 1995-07-18 Otsuka Pharmaceut Factory Inc Nutrition transfusion formulation in 2-room container
JPH0910282A (en) * 1995-06-30 1997-01-14 Material Eng Tech Lab Inc Container for medical treatment with juncture for easy sterilization

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6319149A (en) * 1986-07-10 1988-01-26 株式会社新素材総合研究所 Medical container and its production
JPH0399667A (en) * 1989-09-14 1991-04-24 Terumo Corp Container for medical care
JPH0614975A (en) * 1992-05-03 1994-01-25 Otsuka Pharmaceut Factory Inc Double-chamber container
JPH07178151A (en) * 1993-10-13 1995-07-18 Otsuka Pharmaceut Factory Inc Nutrition transfusion formulation in 2-room container
JPH0910282A (en) * 1995-06-30 1997-01-14 Material Eng Tech Lab Inc Container for medical treatment with juncture for easy sterilization

Also Published As

Publication number Publication date
JP4944850B2 (en) 2012-06-06

Similar Documents

Publication Publication Date Title
JP4236131B2 (en) Medical container
JP4697398B2 (en) Preparation kit for injection and syringe containing medicine
AU6029394A (en) Multiple chamber container
JP2019181181A (en) Sterile flexible package with pressure compensator for dosed reconstitution of fluid medicinal or nutritional substances to be administered to patients by infusion or injection
US9902508B2 (en) Delivery device with separate chambers connectable in fluid communication when ready for use, and related method
JP5498765B2 (en) Medical multi-chamber container
JP2016527048A (en) Intermediate product for manufacturing pre-filled dual chamber syringe or pre-filled dual chamber cartridge and manufacturing method for manufacturing this intermediate product
JP4691773B2 (en) Drug enclosing container set and manufacturing method thereof
JP4944850B2 (en) Drug pre-preparation method
JPH11313871A (en) Infusion vessel
JP2005211558A (en) Medical double-chamber container with unopened use preventive mechanism
JP2004236962A (en) Multi-chamber type medicine container
JP7021303B2 (en) How to make a medical bag
JP4658570B2 (en) Infusion tube, chemical solution administration set and connection adapter
JP2994417B2 (en) Medicine container
TWI220863B (en) Multiple-chamber container reagent
JP4477161B2 (en) Vitamin-containing liquid
JPH0919480A (en) Medical vessel
JP2005067730A (en) Manufacturing method for easily openable content-containing double chamber container
JP5376825B2 (en) Method of injecting chemical solution container, chemical formulation and medical solution into medical infusion bag
JP2002253641A (en) Syringe package for prefilled syringe
JP5568272B2 (en) Lipid-containing vitamin-containing liquid containing iodine
JP2006136744A (en) Medical container
JPH1080465A (en) Vessel for medical treatment
JP2003159308A (en) Medical bag

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090825

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100427

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100726

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100915

A912 Removal of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20101029

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120104

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120302

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150309

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150309

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees